Sharathchandra S Hegde - Net Worth and Insider Trading
Sharathchandra S Hegde Net Worth
The estimated net worth of Sharathchandra S Hegde is at least $2 Million dollars as of 2024-11-10. Sharathchandra S Hegde is the SVP, Research of Theravance Biopharma Inc and owns about 264,444 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. Details can be seen in Sharathchandra S Hegde's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sharathchandra S Hegde has not made any transactions after 2019-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sharathchandra S Hegde
Sharathchandra S Hegde Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sharathchandra S Hegde owns 1 companies in total, including Theravance Biopharma Inc (TBPH) .
Click here to see the complete history of Sharathchandra S Hegde’s form 4 insider trades.
Insider Ownership Summary of Sharathchandra S Hegde
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TBPH | Theravance Biopharma Inc | 2019-03-05 | SVP & Research |
Sharathchandra S Hegde Latest Holdings Summary
Sharathchandra S Hegde currently owns a total of 1 stock. Sharathchandra S Hegde owns 264,444 shares of Theravance Biopharma Inc (TBPH) as of March 5, 2019, with a value of $2 Million.
Latest Holdings of Sharathchandra S Hegde
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TBPH | Theravance Biopharma Inc | 2019-03-05 | 264,444 | 8.94 | 2,364,129 |
Holding Weightings of Sharathchandra S Hegde
Sharathchandra S Hegde Form 4 Trading Tracker
According to the SEC Form 4 filings, Sharathchandra S Hegde has made a total of 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. The most-recent trade in Theravance Biopharma Inc is the sale of 9,033 shares on March 5, 2019, which brought Sharathchandra S Hegde around $223,205.
Insider Trading History of Sharathchandra S Hegde
- 1
Sharathchandra S Hegde Trading Performance
Sharathchandra S Hegde Ownership Network
Ownership Network List of Sharathchandra S Hegde
Ownership Network Relation of Sharathchandra S Hegde
Sharathchandra S Hegde Owned Company Details
What does Theravance Biopharma Inc do?
Who are the key executives at Theravance Biopharma Inc?
Sharathchandra S Hegde is the SVP & Research of Theravance Biopharma Inc. Other key executives at Theravance Biopharma Inc include 10 percent owner Eli Samaha , SVP & Comm & Medical Affairs Rhonda Farnum , and SVP & Development Richard A Graham .
Theravance Biopharma Inc (TBPH) Insider Trades Summary
Over the past 18 months, Sharathchandra S Hegde made no insider transaction in Theravance Biopharma Inc (TBPH). Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 16,734 shares made by Richard A Graham , a net sale of 10,229 shares made by Rhonda Farnum , and a net purchase of 2,498,924 shares made by Eli Samaha .
In summary, during the past 3 months, insiders sold 0 shares of Theravance Biopharma Inc (TBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,963 shares of Theravance Biopharma Inc (TBPH) were sold and 2,498,924 shares were bought by its insiders, resulting in a net purchase of 2,471,961 shares.
Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Theravance Biopharma Inc Insider Transactions
Sharathchandra S Hegde Mailing Address
Above is the net worth, insider trading, and ownership report for Sharathchandra S Hegde. You might contact Sharathchandra S Hegde via mailing address: 901 Gateway Blvd, South San Francisco Ca 94080.